(Circulation. 2000;101:158.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Yale University School of Medicine, New Haven, Conn.
Correspondence to Rachel Lampert, MD, Yale University School of Medicine, Section of Cardiovascular Medicine, FMP 3, 333 Cedar St, New Haven, CT 06520. E-mail rachel.lampert{at}yale.edu
| Abstract |
|---|
|
|
|---|
Methods and ResultsEighteen patients underwent NIPS in the resting-awake state (nonsedated). Ten underwent repeat testing during mental stress (mental arithmetic and anger recall). Induced VT was faster in 5 patients (P=0.03). VT became more difficult to terminate in 5 patients during mental stress; 4 required a shock (P=0.03). There was no change in ease of induction with mental stress. There was no evidence of ischemia on ECG or continuous ejection fraction monitoring. Eight patients received a shock in the resting-awake state and did not perform mental stress. Four underwent repeat NIPS after sedation; 3 then had induced VT terminated with antitachycardia pacing. All patients with an increase in norepinephrine of >50% had alterations in VT that required shock for termination (P<0.01).
ConclusionsMental stress alters VT cycle length and termination without evidence of ischemia. This suggests that mental stress may lead to sudden death through the facilitation of lethal ventricular arrhythmias.
Key Words: stress tachyarrhythmias tachycardia cardioversion defibrillation
| Introduction |
|---|
|
|
|---|
Indirect evidence suggests that sympathetic arousal can trigger arrhythmic events. Ventricular tachycardia (VT), like sudden death, occurs more frequently in the morning, at the time of peak catecholamine levels,9 and of lowest vagal tone,10 as demonstrated in patients with implantable cardioverter-defibrillators (ICDs).11 12 VT occurs more frequently on Mondays in working patients with ICDs,13 suggesting a role for stress. In addition, atrial and ventricular ectopy and nonsustained arrhythmias increase during the stress of being on-call in house officers14 and during exposure to a hostile environment in animals.15 In invasive studies in animals,16 17 stress facilitates the induction of VT.
The population of patients with ICDs provides a unique opportunity to evaluate the effects of mental stress on human arrhythmias. Many patients have arrhythmias with well defined, reproducible characteristics. In addition, their devices allow the performance of noninvasive serial electrophysiological (EP) studies. To determine whether increased sympathetic activation alters the induction, rate, or termination of ventricular arrhythmias, we performed noninvasive EP studies in patients with ICDs and sustained VT, at rest and during varying states of mental arousal and stress.
| Methods |
|---|
|
|
|---|
In all patients, monomorphic VT had been induced and terminated with antitachycardia pacing (ATP) at least twice during previous noninvasive programmed stimulation (NIPS) performed with routine sedation (midazolam and fentanyl). Antiarrhythmic therapy at entry into the present study was unchanged from prior testing. Patients in whom ATP had failed to terminate induced VT were excluded, as were those with decompensated congestive heart failure or other active medical or psychiatric illness or those who were not fluent in English.
Study Protocol
Figure 1
illustrates the study
protocol. All studies were carried out in the morning after an
overnight fast. No sedatives or analgesics were administered. Two
venous cannulas were placed. After blood pool labeling with
99mTc, the miniature radiation detector (c-VEST)
was positioned on the chest for continuous left ventricular
ejection fraction (LVEF) monitoring. At least 30 minutes after
intravenous line and c-VEST placement, baseline
measurements of heart rate, blood pressure, ECG, and LVEF were
obtained. In the initial design of the protocol, each patient was to
undergo NIPS under 3 conditions: resting-awake, mental arithmetic, and
anger recall. These conditions were separated by a brief recovery
period, during which vital signs returned to baseline levels. The NIPS
protocol was initiated 3 minutes into each stage, after the
determination of vital signs, ECG, and LVEF. NIPS was continued until
the induction of an arrhythmia requiring termination by the ICD
or completion of the protocol. Venous blood for
catecholamine measurements was obtained continuously
throughout each stage of the protocol. Ten patients underwent the
mental stress protocol (group 1).
|
In 8 patients, NIPS unexpectedly evoked an arrhythmia that
required a shock for termination in the resting-awake state, and these
patients were not asked to perform mental stress (group 2). Because
this outcome was unanticipated, the first 3 such patients did not
undergo further testing. The subsequent 5 were asked to undergo repeat
testing after sedation with fentanyl and midazolam; 4 agreed, and they
formed group 2a (Figure 1
).
The unexpected behavior of the group 2 patients suggested that the awake state itself may have altered arrhythmic characteristics. To further evaluate this possibility, we retrospectively compared the 18 study patients with a clinically similar cohort of control patients identified from the Yale Electrophysiology Database. Control subjects consisted of patients with ICDs who had reproducibly inducible, pacer-terminated VTs at an initial NIPS and underwent a later study while receiving the same antiarrhythmic regimen, both while under conscious sedation (group 3). The records of all patients with ICDs with ATP programmed (n=111) were reviewed to extract the control group of 40 patients who met these criteria. Temporal variability in VT characteristics was compared between the control group and the 18 study patients.
For comparisons among the groups, "state of arousal" was defined based on the protocol administered: from least aroused (sedated) to resting-awake to most aroused (mental stress).
Programmed Stimulation
A standard NIPS protocol was performed with drive cycle lengths
(CLs) of 500 and 400 ms with up to 3 programmed extrastimuli (PES).
Device settings, including ATP algorithms, programmed at prior NIPS,
remained unchanged throughout the study protocol.
Ventricular effective refractory periods were determined.
The ease of VT induction was quantified ordinally on the basis of the
level of the pacing protocol at which sustained VT was induced: level 1
indicates induction at either CL with 1 PES; level 2, induction with 2
PESs; level 3, induction with 3 PESs; and level 4, completion of
protocol without induction of sustained VT (noninducible). The ease of
termination was also quantified ordinally: level 1 indicates
self-terminating (nonsustained VT [NSVT]); level 2, pacer terminated;
and level 3, shock terminated.
Mental Stress Protocol
The mental stress protocol was administered by a clinical
psychologist (M.M.B.) as previously described.6 Room
lights were dimmed, and a quiet state was maintained. For the
resting-awake stage, patients were encouraged to relax by thinking
about past relaxing situations. During the mental arithmetic stage,
subjects were asked to serially subtract 7 from a 3-digit number. They
were reminded to respond rapidly, and mistakes were corrected harshly.
For anger recall, patients were asked to discuss an annoying or
frustrating event, as the interviewer requested further details and
asked irritating questions.
Radionuclide Angiography
Red blood cells were labeled with 20 to 25 mCi
99mTc according to the standard labeling
technique.18 A gamma camera with a general all-purpose
collimator interfaced with a minicomputer was positioned in the left
anterior oblique view to measure baseline LVEF through the use of
equilibrium radionuclide angiography. The miniature detector of an
ambulatory left ventricular function monitoring device
(C-Vest; Capintec) was then positioned over the left
ventricular blood pool. The device was held in place with a
semirigid plastic vest-like garment. Counts were acquired at 32
s-1 and analyzed off-line with the use
of a dedicated minicomputer to obtain 30-second averaged continuous
trends of LVEF.19 The LVEF reported was the average value
during the first 3 minutes of each stage, before the start of NIPS.
Catecholamine Analysis
Venous blood was continuously withdrawn at a rate of 1 mL/min
with an exfusion pump (Dakmed). Separate samples were collected during
each study phase and immediately placed on ice. Samples were spun and
stored at -70°C at the Yale General Clinical Research Center.
Norepinephrine levels were determined with radioenzymatic
assay or high-performance liquid
chromatography. All samples from a given subject were
analyzed in the same batch. Correlations of
catecholamine levels with arrhythmia
characteristics were based on the sample before arrhythmia (the
1.5 mL within the tubing at the onset of the arrhythmia).
Statistical Analysis
Continuous variables were compared with the use of paired
and unpaired t tests or repeated measures 2-way ANOVA as
appropriate. Ordinal variables were compared with the use of the
nonparametric sign test. Dichotomized variables were
compared with the use of
2 and Fishers exact
tests.
| Results |
|---|
|
|
|---|
|
Resting-Awake Programmed Stimulation
In the resting-awake state, induced VT terminated with ATP or
spontaneously in 10 patients (group 1) but required shock for
termination in 8 patients (group 2). The baseline
norepinephrine level was 3.06±0.50 nmol/L (518±84 pg/mL)
in group 2 patients (levels were available in 4) and 2.78±0.41 nmol/L
(471±69 pg/mL) in group 1 patients (levels were available in 6)
(P=NS). However, during NIPS (before arrhythmia
induction and shock delivery), norepinephrine increased by
34% in group 2 patients but only 10% in group 1 patients
(P=0.01).
Patients Undergoing Mental Stress Protocol (Group 1)
Physiological Changes With Mental
Stress
Heart rate and blood pressure increased and
ventricular refractory periods decreased significantly with
mental stress (Table 2
).
Norepinephrine levels rose during stress (Table 2
),
with return to baseline levels between stress states (2.94+ 0.41
nmol/L, P=NS versus baseline).
|
Changes in Arrhythmia Behavior During Mental
Stress
VT was induced earlier in the protocol during mental stress in 3
of the 10 patients (2 with only NSVT induced during resting-awake, had
sustained VT provoked by 2 PES during stress). In 6 patients, there was
no change, and in 1 patient, induction occurred 1 stage later (Figure 2
, P=NS). The mean induction
stage at rest was 2.4±0.3; with stress, it was 2.0±0.2.
|
VT CLs decreased during mental stress: 5 patients (50%) had a decrease
in CL of
20 ms (P=0.03). The mean CL was 353±24 ms in the
resting-awake state and 314±20 ms with mental stress
(P=0.12).
VT termination became more difficult during mental stress in 5 of the
10 patients (P=0.03) (Figure 3
). This occurred in 1 patient during
mental arithmetic, 3 during anger recall, and 1 during each of the
stress tasks. One patient had NSVT at rest and pacer-terminated VT with
stress. Four patients had pacer-terminated VT (3) or NSVT (1) induced
at rest but VT induced during mental stress that required shock for
termination. Of these, 1 required shock due to failure of ATP, 1
required shock due to induction of VT in a shock-only zone (Figure 4
), and 2 received a shock after ATP
during stress-accelerated VT, of whom 1 had VT of identical CL and
morphology as that terminated with pacing in the resting state (Figure 5
). (The other accelerated patient had
NSVT at rest.) In the remaining 5 patients, VT was terminated with ATP
both at rest and during mental stress. The mean stage of termination
was 1.8±0.1 at rest and 2.4±0.1 with stress.
|
|
|
LVEF and ECG Changes
There were no ST or T-wave changes with mental stress in any
patient. Mean LVEF was 35±6% at baseline and did not change with
mental stress (Table 2
). Only 1 of the 10 patients had a fall in
LVEF of >5% (this patient did not show alterations in any
parameter with mental stress).
Patients Studied Awake and Sedated (Group 2a)
Four patients who received a shock at baseline underwent repeat EP
testing after receiving sedation. There was no change in induction
stage (Figure 2
). Induced VT was significantly slower after
sedation (CL 295±36 ms awake and 370±23 ms sedated,
P=0.05). In 3 patients, the VT CL increased by >20 ms.
After sedation, 3 of the 4 patients had induced VT effectively
terminated with ATP (in 1, the same VT had failed pacer termination
awake, in 2, faster VTs had been induced awake). One of the 4 patients
again required shock while sedated (Figure 3
).
Relation of Catecholamine Levels to Arrhythmia
Characteristics
Comparisons between changes in norepinephrine levels
and changes in arrhythmia characteristics were made in the 9
patients with catecholamine levels available in 2 different
states of arousal: 6 group 1 patients (mental stress versus
resting-awake) and 3 group 2a patients (resting-awake versus sedation)
(Table 3
). Overall, in these patients,
mean norepinephrine levels, which were measured during NIPS
before the induction of VT, were higher in the more aroused state.
Earlier induction and faster VT tended to correlate with a greater rise
in catecholamine levels with arousal. The ease of VT
termination correlated strongly with extent of arousal-induced
catecholamine rise, as shown in Table 3
. When
patients were dichotomized based on change in
norepinephrine level, all 5 patients with a >50% increase
in norepinephrine level in the aroused state (before VT
induction) had induced VT that required shock for termination, whereas
VT in the 4 patients with a smaller increase in
norepinephrine remained pacer terminated
(P<0.001).
|
Retrospective Comparison Awake Versus Sedated States
Temporal variability in VT characteristics was compared between
the study patients (groups 1 and 2), who had undergone a previous
sedated study and the awake study protocol, and the control subjects
(group 3), who had undergone 2 sedated studies on different days. All
were receiving the same antiarrhythmic medications for both
studies.
State of arousal did not influence VT induction, which occurred earlier in the second study in 17% of awake patients and 28% of sedated patients (P=NS). Mean VT CL decreased at the second study by 65±17 ms in the awake versus 17±12 ms in the sedated patients (P=0.03). Arousal state strongly influenced VT termination. Although all patients had pacer-terminated VT at the first, sedated, study, termination of VT at the second study required shock in 8 of 18 (44%) of the awake patients but only 4 of 40 (10%) of the sedated patients (P=0.002).
| Discussion |
|---|
|
|
|---|
Unexpectedly, despite the inclusion of only patients with reproducible termination of VT by ATP at previous sedated noninvasive EP study (and no change in antiarrhythmic medications), 40% received shocks for induced VT in the "resting" awake state. To evaluate whether the awake state itself altered VT, 4 patients receiving shocks while awake underwent repeat testing after sedation; 3 again had pacer-terminated VT. The environment of the EP laboratory and the ongoing NIPS protocol may have produced anxiety or fear in some patients, changing the "resting" awake state to that of heightened arousal. The far greater increase in norepinephrine during NIPS (before VT induction) in patients proceeding to receive shocks supports this hypothesis, underscoring the influence of sympathetic tone on arrhythmia behavior. Although a pharmacological effect of the sedating agents cannot be excluded, studies in isolated tissue preparations or denervated hearts, which evaluated the effects of drugs in the absence of autonomic mediation, have not shown either midazolam or fentanyl to alter ventricular refractory periods or other EP parameters.22 23
To exclude the possibility that the unexpected changes in arrhythmia behavior were due only to day-to-day variability of response to EP testing,24 we retrospectively compared the consistency of response to NIPS over time in a group of similar patients (with inducible pacer-terminated VT) who had undergone 2 NIPS while sedated. The results of NIPS varied minimally between 2 sedated studies, unlike the dramatic changes seen with a second study in the awake state, again suggesting that due to lack of sedation, a higher state of arousal increased the lethal potential of VT.
The results of previous studies in animals support our findings. Both Lown et al,16 in a healthy canine model, and Kirby et al,17 in a porcine model of scar-related VT, found VT to be more readily inducible and faster in animals stressed by being lifted in a sling. The present study demonstrates that not only the primitive fight-or-flight responses of animals but the more complex human emotions of anger, anxiety, and performance stress alter arrhythmias. In addition, although these studies induced only rapid VTs or NSVTs, the selection of patients with stable monomorphic VT in the present study allowed an evaluation of the mode of VT termination as well.
Although multiple epidemiological studies have shown an increase in sudden cardiac death in populations undergoing the stress of natural disaster or war,1 2 3 the physiological link between stress and sudden cardiac death remains unexplained. Ischemia is often hypothesized to precipitate stress-induced cardiac events. Mental stress testing in the laboratory setting can induce ischemia,4 5 6 7 and anger can precipitate myocardial infarction.25 To evaluate whether ischemia might underlie stress-induced changes in arrhythmia, both ECG and ambulatory LVEF (a more sensitive indicator of ischemia than repolarization changes4 ) were monitored. No changes were seen in 9 of the 10 patients, suggesting that direct effects of the sympathetic nervous system on the VT circuit, rather than ischemia, effected the stress-related changes in VT behavior. This further implies that stress may directly cause arrhythmic sudden death in susceptible patients through the facilitation of lethal arrhythmias.
Stress-induced changes in EP properties such as repolarization time and conduction velocity may underlie the effects on arrhythmias seen in the present study. Toivonen et al26 showed changes in repolarization in healthy house officers exposed to the sudden stress of an on-call alarm. Repolarization also exhibits diurnal variation, further suggesting an influence of changing adrenergic tone.27 The signal-averaged ECG has shown changes with both mental stress28 and time of day,29 implying sympathetic effects on conduction. Analogous changes in the reentrant circuit in patients with monomorphic VT may explain the changes seen in the present study. Although refractory periods, conduction times, and the excitable gap of the VT circuit cannot be measured without invasive mapping, the changes seen in CL and response to overdrive pacing may reflect changes in these properties of the VT circuit.
Study Limitations
Patients who received a shock at baseline did not undergo mental
stress because we believe that the risk of delivering a second shock
with the patient awake was not acceptable. We cannot exclude the
possibility that the changes seen could reflect regression to the mean
as an artifact of the protocol (ie, would the patients who received a
shock at baseline have been pacer terminated with mental stress?).
However, three fourths of the patients who received a shock who
underwent testing while sedated then had pacer-terminated VT, and
catecholamine levels correlated with arousal state;
artifactual changes in response seem highly unlikely. Similarly, the
order of testing was not randomized. However, catecholamine
levels returned to baseline between stressors, suggesting that the
stressor itself, rather than a cumulative effect of testing, was
responsible for the changes seen.
Only 1 woman was enrolled in the study (5%). Whether the effects of mental stress and arousal state on arrhythmia differ in women requires further evaluation.
Conclusions and Implications
Mental stress alters VT CL and termination, suggesting that
autonomic arousal may lead to sudden death through the facilitation of
lethal ventricular arrhythmias. Whether these
results can be extrapolated to patients without a preceding history of
VT is unknown. In patients with defibrillators, as well as in all
patients at risk for ventricular arrhythmias,
therapies aimed at blocking the sympathetic response to stress may
decrease the frequency and lethality of arrhythmic events.
| Acknowledgments |
|---|
Received April 30, 1999; revision received August 5, 1999; accepted August 17, 1999.
| References |
|---|
|
|
|---|
2. Meisel SR, Kutz I, Dayan KI, Pauzner H, Chetboun I, Arbel Y, Daviv D. Effect of Iraqi missile war on incidence of acute myocardial infarction and sudden death in Israeli civilians. Lancet. 1991;338:660661.[Medline] [Order article via Infotrieve]
3. Trichopoulos D, Katsoutanni K, Zavitsanos X, Tzonou A, Dalla-Vorgia P. Psychological stress and fatal heart attack: the Athens (1981) earthquake natural experiment. Lancet. 1983;1:441443.[Medline] [Order article via Infotrieve]
4. Rozanski A, Bairey CN, Krantz DS, Friedman J, Resser KJ, Morell M, Hilton-Chalfen S, Hestrin L, Bietendorf J, Berman DS. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N Engl J Med. 1988;318:1005s1012s.
5.
Goldberg AD, Becker LC, Bonsall R, Cohen JD, Ketterer
MW, Kaufman PG, Krantz DS, Light KC, McMahon RP, Noreuil T, Pepine CJ,
Raczynski J, Stone PH, Straother D, Taylor H, Sheps DS.
Ischemic, hemodynamic, and neurohormonal
responses to mental and exercise stress. Circulation. 1996;94:24022409.
6. Burg MM, Jain D, Soufer R, Kerns RD, Zaret B. Role of behavioral and psychological factors in mental stress-induced silent left ventricular dysfunction in coronary artery disease. J Am Coll Cardiol. 1993;22:440448.[Abstract]
7.
Blumenthal JA, Jiang W, Waugh RA, Frid DJ, Morris JJ,
Coleman RE, Hanson M, Babyak M, Thyrum ET, Krantz DS, OConnor C.
Mental stress-induced ischemia in the laboratory and ambulatory
ischemia during daily life. Circulation. 1995;92:21022108.
8. Gottdiener JS, Krantz DS, Howell RH, Hecht GM, Klein J, Falconer JJ, Rozanski A. Induction of silent myocardial ischemia with mental stress testing: relation to the triggers of ischemia during daily life activities and to ischemic functional severity. J Am Coll Cardiol. 1994;24:16451651.[Abstract]
9. Turton MB, Deegan T. Circadian variations of plasma catecholamine, cortisol, and immunoreactive insulin concentrations in supine subjects. Clin Chim Acta. 1974;55:389397.[Medline] [Order article via Infotrieve]
10.
Huikuri HV, Niemela MJ, Ojala S, Airaksinen KE.
Circadian rhythms of frequency domain measures of heart rate
variability in healthy subjects and patients with coronary
artery disease. Circulation. 1994;90:121126.
11.
Lampert R, Rosenfeld L, Batsford W, Lee F, McPherson C.
Circadian variation of sustained ventricular
tachycardia in patients with coronary artery
disease and implantable cardioverter-defibrillators.
Circulation. 1994;90:241247.
12.
Tofler GH, Gebara OCE, Mittleman MA, Taylor P, Siegel
W, Venditti FJ, Rasmussen CA, Muller JE. Morning peak in
ventricular tachyarrhythmias detected by
time of implantable cardioverter/defibrillator therapy.
Circulation. 1995;92:12031208.
13.
Peters RW, McQuillan S, Resnick SK, Gold MR. Increased
Monday incidence of life-threatening ventricular
arrhythmias. Circulation. 1996;94:13461349.
14. Stamler JS, Goldman ME, Gomes J, Matz D, Horowitz SF. The effect of stress and fatigue on cardiac rhythm in medical interns. J Electrocardiol. 1992;25:333338.[Medline] [Order article via Infotrieve]
15. Sgoifo A, Stilli D, Aimi B, Parmigiani SMM, Musso E. Behavioral and electrocardiographic responses to social stress in male rats. Physiol Behav. 1994;55:209216.[Medline] [Order article via Infotrieve]
16.
Lown B, Verrier R, Corbalan R. Psychologic stress and
threshold for repetitive ventricular response.
Science. 1973;182:834836.
17.
Kirby DA, Pinto JMB, Hottinger S, Johnson DA, Lown B.
Behavioral arousal enhances inducibility and rate of
ventricular tachycardia. Am J
Physiol. 1991;261:H1734H1739.
18.
Callahan R, Froelich J, McKusick K, Leppo J, Strauss H.
A modified method for the in vivo labeling of red blood cells with
Tc-99 m: concise communication. J Nucl Med. 1982;23:315318.
19. Jain D, Zaret B. Ambulatory monitoring of left ventricular function. In: Gerson M, ed. Cardiac Nuclear Medicine. 3rd ed. New York, NY: McGraw-Hill; 1996:415426.
20. Dimsdale JE, Ziegler JE. What do plasma and urinary measures of catecholamines tell us about human response to stressors? Circulation. 1991;83(suppl II):II-36II-42.
21.
Becker LC, Pepine CJ, Bonsall R, Cohen JD,
Goldberg AD, Coghlan C, Stone PH, Forman S, Knatterud G, Sheps DS,
Kaufman PG. Left ventricular, peripheral
vascular, and neurohumoral responses to mental stress in normal
middle-aged men and women. Circulation. 1996;94:27682777.
22. Nagy A, Papp J, Ungi I. Effect of the combination of mexiletine and midazolam on the electrical and mechanical activity of cardiac preparations. Pharm Res. 1992;25:152153.
23.
Alvarez L, Escudero C, Carmona J, Silva L,
Castillo-Olivares J. Effect of fentanyl on cardiac automaticity and
conduction: direct or mediated action? Eur Heart J. 1992;13:12771281.
24. McPherson CA, Rosenfeld LE, Batsford WP. Day-to-day reproducibility of responses to right ventricular programmed electrical stimulation: implications for serial drug testing. Am J Cardiol. 1985;55:689695.[Medline] [Order article via Infotrieve]
25.
Mittleman MA, Maclure M, Sherwood JB, Mulry RP, Tofler
GH, Jacobs SC, Friedman R, Benson H, Muller JE. Triggering of acute
myocardial infarction onset by episodes of anger.
Circulation. 1995;92:17201725.
26. Toivonen L, Helenius K, Viitasalo M. Electrocardiographic repolarization during stress from awakening on alarm call. J Am Coll Cardiol. 1997;30:774779.[Abstract]
27.
Bexton RS, Camm AJ. Diurnal variation of the QT
interval: influence of the autonomic nervous system. Br
Heart J. 1986;55:253258.
28. Folino AF, Buja G, Turrini P, Oselladore L, Nava A. The effects of sympathetic stimulation induced by mental stress on signal-averaged electrocardiogram. Int J Cardiol. 1994;48:279285.
29. Goldhammer E, Abinader EG. Circadian fluctuations of late potentials detected by signal-averaged electrocardiogram. Am Heart J. 1996;132:12981299.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
K. C. van den Broek, I. Nyklicek, P. H. van der Voort, M. Alings, A. Meijer, and J. Denollet Risk of ventricular arrhythmia after implantable defibrillator treatment in anxious type D patients. J. Am. Coll. Cardiol., August 4, 2009; 54(6): 531 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Ladwig, J. Baumert, B. Marten-Mittag, C. Kolb, B. Zrenner, and C. Schmitt Posttraumatic Stress Symptoms and Predicted Mortality in Patients With Implantable Cardioverter-Defibrillators: Results From the Prospective Living With an Implanted Cardioverter-Defibrillator Study Arch Gen Psychiatry, November 1, 2008; 65(11): 1324 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Heinz Arrhythmias in the ICU: What Do We Know? Am. J. Respir. Crit. Care Med., July 1, 2008; 178(1): 1 - 2. [Full Text] [PDF] |
||||
![]() |
M. Hassan, K. M. York, H. Li, Q. Li, Y. Gong, T. Y. Langaee, R. B. Fillingim, J. A. Johnson, and D. S. Sheps Association of {beta}1-Adrenergic Receptor Genetic Polymorphism With Mental Stress-Induced Myocardial Ischemia in Patients With Coronary Artery Disease Arch Intern Med, April 14, 2008; 168(7): 763 - 770. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Dimsdale Psychological Stress and Cardiovascular Disease J. Am. Coll. Cardiol., April 1, 2008; 51(13): 1237 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Ziegelstein Acute Emotional Stress and Cardiac Arrhythmias JAMA, July 18, 2007; 298(3): 324 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ramachandruni, R. B. Fillingim, S. P. McGorray, C. M. Schmalfuss, G. R. Cooper, R. S. Schofield, and D. S. Sheps Mental Stress Provokes Ischemia in Coronary Artery Disease Subjects Without Exercise- or Adenosine-Induced Ischemia J. Am. Coll. Cardiol., March 7, 2006; 47(5): 987 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Gerin, K. W. Davidson, N. J. S. Christenfeld, T. Goyal, and J. E. Schwartz The Role of Angry Rumination and Distraction in Blood Pressure Recovery From Emotional Arousal Psychosom Med, January 1, 2006; 68(1): 64 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Dunbar Psychosocial Issues of Patients With Implantable Cardioverter Defibrillators Am. J. Crit. Care., July 1, 2005; 14(4): 294 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Vale Psychosocial stress and cardiovascular diseases Postgrad. Med. J., July 1, 2005; 81(957): 429 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Taggart, P. Sutton, C. Redfern, V. N. Batchvarov, K. Hnatkova, M. Malik, U. James, and A. Joseph The Effect of Mental Stress on the Non-Dipolar Components of the T Wave: Modulation by Hypnosis Psychosom Med, May 1, 2005; 67(3): 376 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Critchley, P. Taggart, P. M. Sutton, D. R. Holdright, V. Batchvarov, K. Hnatkova, M. Malik, and R. J. Dolan Mental stress and sudden cardiac death: asymmetric midbrain activity as a linking mechanism Brain, January 1, 2005; 128(1): 75 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Burg, R. Lampert, T. Joska, W. Batsford, and D. Jain Psychological Traits and Emotion-Triggering of ICD Shock-Terminated Arrhythmias Psychosom Med, November 1, 2004; 66(6): 898 - 902. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Soufer Neurocardiac Interaction During Stress-Induced Myocardial Ischemia: How Does the Brain Cope? Circulation, September 28, 2004; 110(13): 1710 - 1713. [Full Text] [PDF] |
||||
![]() |
R. Lampert, C. A. McPherson, J. F. Clancy, T. L. Caulin-Glaser, L. E. Rosenfeld, and W. P. Batsford Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2293 - 2299. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Kop, D. S. Krantz, B. D. Nearing, J. S. Gottdiener, J. F. Quigley, M. O'Callahan, A. A. DelNegro, T. D. Friehling, P. Karasik, S. Suchday, et al. Effects of Acute Mental Stress and Exercise on T-Wave Alternans in Patients With Implantable Cardioverter Defibrillators and Controls Circulation, April 20, 2004; 109(15): 1864 - 1869. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Schwartz, W. Gerin, K. W. Davidson, T. G. Pickering, J. F. Brosschot, J. F. Thayer, N. Christenfeld, and W. Linden Toward a Causal Model of Cardiovascular Responses to Stress and the Development of Cardiovascular Disease Psychosom Med, January 1, 2003; 65(1): 22 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lampert, T. Joska, M. M. Burg, W. P. Batsford, C. A. McPherson, and D. Jain Emotional and Physical Precipitants of Ventricular Arrhythmia Circulation, October 1, 2002; 106(14): 1800 - 1805. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lampert, S. J. Baron, C. A. McPherson, and F. A. Lee Heart Rate Variability During the Week of September 11, 2001 JAMA, August 7, 2002; 288(5): 575 - 575. [Full Text] [PDF] |
||||
![]() |
V. Dorges, V. Wenzel, S. Dix, A. Kuhl, T. Schumann, M. Huppe, H. Iven, and K. Gerlach The Effect of Midazolam on Stress Levels During Simulated Emergency Medical Service Transport: A Placebo-Controlled, Dose-Response Study Anesth. Analg., August 1, 2002; 95(2): 417 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
R J P LEWIN, D J FRIZELLE, and G C KAYE A rehabilitative approach to patients with internal cardioverter-defibrillators Heart, April 1, 2001; 85(4): 371 - 372. [Full Text] |
||||
![]() |
T. M. Ramahi, M. D. Longo, A. R. Cadariu, K. Rohlfs, S. A. Carolan, K. M. Engle, H. Samady, and F. J. T. Wackers Left ventricular inotropic reserve and right ventricular function predict increase of left ventricular ejection fraction after beta-blocker therapy in nonischemic cardiomyopathy J. Am. Coll. Cardiol., March 1, 2001; 37(3): 818 - 824. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |